Roche loses patent opposition in India
In another blow to multinational pharmaceutical companies in India, the Chennai Patent Office has invalidated a key patent owned by Swiss drug maker F Hoffmann La Roche, allowing generic competitors to enter the market
In the May 5 decision, S P Subramanian, the assistant controller of patents and designs, said that the patent covering Valcyte (valganciclovir hydrochloride) lacks inventive step and does not demonstrate significantly improved efficacy over previous compounds, as required by India's...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.